<unk> , sold under the brand name Kimmtrak, is an anti-cancer medication used to treat uveal melanoma (eye cancer). The most common side effects include cytokine release syndrome, rash, pyrexia (fever), pruritus (itching), fatigue, nausea, chills, abdominal pain, edema, hypotension, dry skin, headache, and vomiting.<unk>  is a bispecific gp100 peptide-HLA-directed CD3 T cell engager. It was approved for medical use in the United States in January 2022.
Tebentafusp
Titermax
Clinatec
Rupatadine
Loratadine
Naldecon
Nalmefene
Telotristat ethyl